MONTREAL--(BUSINESS WIRE)-- Resonant Medical, an innovator in 3D soft tissue planning, image-guidance and adaptive radiotherapy products, today announced a collaboration with Amerinet, a leading U.S. group purchasing organization.
Through Amerinet, Resonant Medical will provide hospitals and cancer clinics with the Clarity System, an FDA-cleared solution that is both non-invasive and non-ionizing for Image-Guided Radiation Therapy (IGRT) for soft tissue cancers, such as prostate and breast. The Clarity System represents a significant evolution in radiation treatment imaging for soft tissue cancers by enabling radiation oncologists to visualize the target anatomy during each step of the patient flow from simulation, planning through treatment.
This three-year agreement will allow all Amerinet members to purchase the Clarity System for soft tissue IGRT under the cost effective product configuration solutions of the contract. As part of the contract launch, Amerinet will be sponsoring a “Target Buy” Program for all of its member facilities. This Target Buy opportunity will include special incentives to all member customers who wish to purchase the Soft Tissue IGRT technology during the months of May and June.
“Our collaboration with Amerinet demonstrates our commitment to helping cancer centers advance patient care by making significant improvements in radiation therapy planning, verification and delivery,” said Stephen Whisenhunt, vice president of global sales and marketing for Resonant Medical. “We are excited to partner with Amerinet to support a more streamlined, efficient process for medical institutions adopting the Clarity System and integrating the technology into their radiation therapy planning and treatment delivery protocols.”
The Clarity Soft Tissue IGRT System provides a state-of-the-art solution for any radiation oncology center. This advanced technology is compatible with any make, model or year of linear accelerator and CT scanner.
As a leading national healthcare group purchasing organization, Amerinet strategically partners with acute and alternate care providers to reduce costs and improve quality through its performance solutions. Built on a foundation of data, savings and trust, and supported by a team of clinical and supply chain experts, Amerinet enriches healthcare delivery for its members and the communities they serve. To learn more about the Amerinet difference, visit www.amerinet-gpo.com.
About Resonant Medical
Resonant Medical (Montreal, Canada) develops, manufactures and commercializes 3D soft tissue hybrid planning, image-guidance, and adaptive radiotherapy products. Resonant’s technologies are available in cancer centers throughout the U.S., Canada and Europe, helping cancer centers make significant improvements in patient care.
For further information visit: www.resonantmedical.com.
KEYWORDS: North America Canada
INDUSTRY KEYWORDS: Health Hospitals Medical Devices Oncology Radiology